Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma

Conclusion: Relative to CT, CXCR4-directed PET/CT led to AA changes for 27 of 100 patients. Chemokine receptor PET/CT may improve current diagnostic algorithms and influence management relative to CT alone, potentially obviating some biopsies.

Source: Journal of Nuclear Medicine - December 1, 2023 Category: Nuclear Medicine Authors: Duell, J., Buck, A. K., Hartrampf, P. E., Schlotelburg, W., Schneid, S., Weich, A., Dreher, N., Lapa, C., Kircher, M., Higuchi, T., Samnick, S., Serfling, S. E., Raderer, M., Rasche, L., Einsele, H., Topp, M. S., Kosmala, A., Werner, R. A. Tags: Clinical Investigations Source Type: research